Koniec z pojazdami, które woziły pacjentów przez kilkadziesiąt lat. Na warszawskich ulicach nie zobaczymy już białych karetek pogotowia. Pojazdy ratunkowe, do których się przyzwyczailiśmy ...

GSK recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these ...

GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...

On April 3, 2025, GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District Court for the District of Delaware. GSK filed suit ...

Amid the current market turmoil, it is worth remembering that the pharmaceutical industry must continue its normal business of ensuring that it has products to sell in 10 years, with GSK (GSK) signing ...

Big pharmaceutical companies have been making deals for technologies that could help them get their molecules through this protective membrane and now GSK is joining in, striking up an alliance ...

LOS ANGELES, April 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier. ABL Bio has ...

FOR YOUR MONDAY. ALL NEW TONIGHT. THE PIRATES SAY THE CLEMENTE LOGO WILL BE PUT BACK ON THE RIGHT FIELD WALL AT PNC PARK. PRESIDENT TRAVIS WILLIAMS SAYING TODAY IT WAS AN OVERSIGHT TO NOT KEEP THE ...

As part of the agreement, ABL Bio will transfer Grabody-B-related technology and know-how to GSK, while GSK will assume responsibility for preclinical and clinical development, manufacturing ...

GSK and ABL Bio have entered into an agreement worth over £2bn to develop new drugs for neurodegenerative diseases. The global licensing deal will allow GSK to use ABL Bio’s blood-brain barrier (BBB) ...

After baseball fans and the family of Roberto Clemente expressed outrage over the Pittsburgh Pirates’ removal of the Major League Baseball Hall of Famer’s logo from the outfield wall at the ...